Sarkar, Sayantani <br/><br/>
Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.  [electronic resource] 

 -  Endocrine-related cancer  Feb 2014 
 - 113-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-6821 
<br/><br/><label>Standard No.: </label>10.1530/ERC-13-0315  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Cadherins--metabolism<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Checkpoint Kinase 1<br/>Checkpoint Kinase 2--genetics<br/>Flow Cytometry<br/>G2 Phase--drug effects<br/>Glycogen Synthase Kinase 3--metabolism<br/>Glycogen Synthase Kinase 3 beta<br/>Humans<br/>Pancreatic Neoplasms--drug therapy<br/>Protein Kinases--genetics<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>RNA--chemistry<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Withanolides--pharmacology<br/>Wnt Signaling Pathway--drug effects<br/>beta Catenin--metabolism